FOR BOARDS & LEADERSHIP TEAMS

Challenge assumptions before major commitments.

I bring independent scientific, clinical and entrepreneurial judgment to board and leadership discussions in ophthalmic technology.

Independent judgment

Separate the evidence from the narrative and make the important uncertainties visible.

Connect clinical need, differentiation, development risk and adoption across the portfolio.

Ask the difficult question early—before capital, time or organizational attention becomes committed.

Bring experience from research, product development, company building and clinical adoption into the room.

A USEFUL STARTING POINT

Share the board or strategic context, the decision ahead and where an independent perspective may help.

The aim is not another opinion. It is a clearer decision, a visible risk and an actionable next question.

Scope and availability are agreed for each engagement.